NCT06630013 A New Ultrasound Score for Swallowing Disorders Diagnosis in Difficult-to-wean Tracheostomised Patients
| NCT ID | NCT06630013 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hopital Forcilles |
| Condition | Deglutition Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 114 participants |
| Start Date | 2024-07-09 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 114 participants in total. It began in 2024-07-09 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Swallowing Disorders (SD) is commonly observed in intensive care unit (ICU) patients. Disruption to the upper airway by way of a tracheostomy may lead to physiological and/or biomechanical changes to the swallow, thereby increasing dysphagia risk. SD is independently associated with adverse outcomes including respiratory complications, nutritional compromise, and even death. Experts recommend a systematic bedside screening. Most algorithms include the water swallow test followed by expert comprehensive swallowing assessments of screening positive patients. However, the clinical examination lacks precision. Complementary examinations, such as videofluoroscopy or Fiberoptic Endoscopic Evaluation of Swallowing (FEES), are irradiating or invasive, consume numerous resources and are difficult to access. No current consensus exists on how to best approach to evaluate ICU patients at risk. In this context, US imaging has garnered increased interest for assessing swallowing disorders. Recognised for its non-invasive nature and its ability to overcome conventional constraints, this approach, enabling both qualitative and quantitative analysis of multiple structures, would enhance the precision in targeting structures for rehabilitation. The researchers intend to create an ultrasound diagnostic model for difficult-to-wean trahceostomised patients. Additionally, they aim to evaluate the reliability and accuracy of this model. During an nineteen-months period, we will enrolled one hundred and nineteen difficult-to-wean tracheostomised patients at Forcilles's Hospital, Universitary Hospital of Dijon, Béthune Hospital and Bourgon Jallieu Hospital. All patients will have a FEES evaluation. The ultrasonographer will be blinded to the patient's status and prior clinical or imaging assessments. Ultrasound assessment will focus on evaluating the movements or morphology of structures such as the tongue, laryngeal movement, or suprahyoid muscles. A global ultrasound diagnostic model will be developed after selecting variables in logistic multivariable regression. Its sensitivity and specificity and prediction value will be estimated. The constructed model will be transformed in an easy-to-use scoring system. The study anticipates establishing an association between ultrasound markers and swallowing disorders, aiming to enhance early detection for tailored management strategies, providing a non-invasive alternative to videofluoroscopy or FEES.
Eligibility Criteria
Inclusion Criteria: * Patients admitted to ICU and tracheostomised for difficult-to-wean reasons ; * Patients with a medical indication for nasofibroscopy ; * Medical prescription for physiotherapy assessment ; * Ultrasound operator available ; * Patient at least 18 years old at the time of inclusion; * Oral, free, informed and express patient consent Exclusion Criteria: * Patient with total laryngectomy; * History of swallowing disorders prior to critical care admission; * History of central nervous system disorders (stroke, Parkinson's disease, etc.) * Patient admitted to intensive care following central neurological injury; * Patient with spinal cord injury above C5 ; * Patient's refusal to participate in the study ; * Known pregnancy ; * Cognitive impairment incompatible with understanding instructions; * Patient under guardianship; * Patient with limited care.
Contact & Investigator
DIAZ LOPEZ Carlos, PhD st
PRINCIPAL INVESTIGATOR
Hopital Forcilles
Frequently Asked Questions
Who can join the NCT06630013 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Deglutition Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06630013 currently recruiting?
Yes, NCT06630013 is actively recruiting participants. Contact the research team at aleneindre@cognacq-jay.fr for enrollment information.
Where is the NCT06630013 trial being conducted?
This trial is being conducted at Beuvry, France, Dijon, France, Lyon, France, Férolles-Attilly, France.
Who is sponsoring the NCT06630013 clinical trial?
NCT06630013 is sponsored by Hopital Forcilles. The principal investigator is DIAZ LOPEZ Carlos, PhD st at Hopital Forcilles. The trial plans to enroll 114 participants.